• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CASHEL OPTEASE RETR FILTER 55 JUGULAR; FILTER, INTRAVASCULAR, CARDIOVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CASHEL OPTEASE RETR FILTER 55 JUGULAR; FILTER, INTRAVASCULAR, CARDIOVASCULAR Back to Search Results
Model Number 466F220AJ
Device Problem Material Frayed (1262)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/02/2019
Event Type  malfunction  
Manufacturer Narrative
(b)(6).Device history record (dhr) review was conducted and the product met quality requirements for product acceptance.This device was received for analysis but the engineering report is not yet available.However, it will be submitted within 30 days upon receipt.
 
Event Description
During use, an optease sheath was attempted to be inserted, however the marker was scratch (frayed).There was no patient injury.Therefore the optease was replaced with a new device and the procedure was completed.The target lesion was not tortuous, calcified, or stenosed.The product stored, handled, inspected and prepped according to the instructions for use (ifu) with no unusual or damages noted about the delivery sheath prior to use.The device package was not damaged.Excessive force was not used when the device was removed from the packaging.There was no excessive force used during the procedure.The doctor requested a customer letter.The device is available for analysis.No other information was provided.
 
Manufacturer Narrative
During use, an optease sheath was attempted to be inserted; however the marker was scratch (frayed).There was no patient injury.Therefore the optease was replaced with a new device and the procedure was completed.The target lesion was not tortuous, calcified, or stenosed.The product was stored, handled, inspected and prepped according to the instructions for use (ifu) with no unusual or damages noted about the delivery sheath prior to use.The device package was not damaged.Excessive force was not used when the device was removed from the packaging.There was no excessive force used during the procedure.No other information was provided.The product was returned for analysis.A non-sterile optease retrieval filter 55 jugular cannula sheath introducer and a vessel dilator were received for analysis inside a plastic bag.Per visual analysis, the vessel dilator was received fully inserted into the cannula sheath.The cannula sheath introducer was received frayed/ split/ torn damaged on tip of unit.No original tray/packaging was returned for analysis as to determine if the observed damage condition could be caused due to improper packaging.No other anomalies were found.Per microscopic analysis the tip of the cannula (cannula end) was confirmed to be frayed/split/torn as well as material deformation and elongations on the surroundings of the observed tip damaged.Elongations is a common characteristic of pieces which were stretched / pulled until separation.Based on the available evidence, it is very likely that the frayed/split/torn condition found on the cannula tip was a result of the interaction with an unknown object that cause the observed material deformation and the frayed/split/torn condition.A product history record (phr) review of lot 17556193 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported ¿catheter sheath introducer (csi) - frayed/split/torn - in patient¿ was confirmed through analysis of the returned device.The exact cause of the event could not be determined during analysis.Based on the information available for review, procedural factors may have contributed to the event as evidenced by deformation and elongations noted on the outer tip during analysis.According to the safety information in the instructions for use ¿if strong resistance is met during any stage of the procedure, discontinue the procedure and determine the cause before proceeding.Caution: to avoid damage to the sheath introducer tip, do not withdraw the dilator until the sheath introducer tip is at the desired location in the ivc.¿ neither the phr review nor the product analysis suggests that the event experienced by the customer could be related to the manufacturing process; therefore, no corrective/preventive action will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTEASE RETR FILTER 55 JUGULAR
Type of Device
FILTER, INTRAVASCULAR, CARDIOVASCULAR
Manufacturer (Section D)
CORDIS CASHEL
cahir road
cashel, tipperary 0000
EI  0000
MDR Report Key8607371
MDR Text Key145028068
Report Number9616099-2019-02929
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
PMA/PMN Number
K034050
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign
Type of Report Initial,Followup
Report Date 05/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/14/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2019
Device Model Number466F220AJ
Device Catalogue Number466F220AJ
Device Lot Number17556193
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/25/2019
Date Manufacturer Received05/22/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-